Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Operating Expenses (2017 - 2020)

Historic Operating Expenses for Cogent Biosciences (COGT) over the last 4 years, with Q4 2020 value amounting to $11.5 million.

  • Cogent Biosciences' Operating Expenses fell 1220.11% to $11.5 million in Q4 2020 from the same period last year, while for Sep 2021 it was $11.5 million, marking a year-over-year decrease of 8750.19%. This contributed to the annual value of $333.4 million for FY2025, which is N/A changed from last year.
  • Cogent Biosciences' Operating Expenses amounted to $11.5 million in Q4 2020, which was down 1220.11% from $57.5 million recorded in Q3 2020.
  • Over the past 5 years, Cogent Biosciences' Operating Expenses peaked at $57.5 million during Q3 2020, and registered a low of $7.9 million during Q1 2017.
  • For the 4-year period, Cogent Biosciences' Operating Expenses averaged around $14.1 million, with its median value being $12.0 million (2018).
  • Within the past 5 years, the most significant YoY rise in Cogent Biosciences' Operating Expenses was 34049.48% (2020), while the steepest drop was 4202.06% (2020).
  • Over the past 4 years, Cogent Biosciences' Operating Expenses (Quarter) stood at $9.0 million in 2017, then soared by 42.27% to $12.8 million in 2018, then grew by 1.87% to $13.0 million in 2019, then dropped by 12.2% to $11.5 million in 2020.
  • Its Operating Expenses stands at $11.5 million for Q4 2020, versus $57.5 million for Q3 2020 and $7.9 million for Q2 2020.